title: ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice.
abstract: ADAMTS13, a metalloprotease, plays a pivotal role in preventing spontaneous microvascular thrombosis by cleaving hyperactive ultra large von Willebrand factor multimers into smaller, less active multimers. Reduced ADAMTS13 activity in plasma has been described in many diseases associated with systemic inflammation. It remains uncertain, however, whether ADAMTS13 contributes to disease pathogenesis or rather simply serves as an inflammation-associated marker. We hypothesized that, by decreasing vascular inflammation, ADAMTS13 reduces the development of early atherosclerotic plaques. Using intravital fluorescence microscopy, we observed excessive leukocyte adhesion and accelerated atherosclerotic plaque formation at the carotid sinus of Adamts13(-/-)/ApoE(-/-) mice compared with ApoE(-/-) mice fed a high-fat Western diet. At 4 months of age, there was a significant increase in atherosclerosis in the aorta and aortic sinus of Adamts13(-/-)/ApoE(-/-) mice compared with ApoE(-/-) mice. Interestingly, we detected a 2-fold increase in macrophage recruitment to the atherosclerotic plaque of the Adamts13(-/-)/ApoE(-/-) mice compared with ApoE(-/-) mice, suggesting that the atherosclerotic lesions in these mice were not only larger but also more inflammatory. These findings reveal a new functional role for the antithrombotic enzyme ADAMTS13 in reducing excessive vascular inflammation and plaque formation during early atherosclerosis.
authors: Department of Internal Medicine, University of Iowa, Iowa City, USA.
authors: Chintan
authors: C
authors: Gandhi
authors: Mohammad Moshahid
authors: MM
authors: Khan
authors: Steven R
authors: SR
authors: Lentz
authors: Anil K
authors: AK
authors: Chauhan
mesh_terms: D000071120:ADAMTS13 Protein; D000818:Animals; D001011:Aorta / Q000378:metabolism / Q000473:pathology; D001057:Apolipoproteins E / Q000235:genetics / Q000378:metabolism*; D002448:Cell Adhesion; D024042:Collagen Type I / Q000378:metabolism; D024043:Collagen Type II / Q000378:metabolism; D004041:Dietary Fats / Q000008:administration & dosage / Q000633:toxicity; D005260:Female; D007150:Immunohistochemistry; D007962:Leukocytes / Q000378:metabolism / Q000473:pathology; D008055:Lipids / Q000097:blood; D008264:Macrophages / Q000378:metabolism; D008297:Male; D008666:Metalloendopeptidases / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008856:Microscopy, Fluorescence; D058226:Plaque, Atherosclerotic / Q000209:etiology / Q000235:genetics / Q000378:metabolism*; D012850:Sinus of Valsalva / Q000378:metabolism / Q000473:pathology; D013997:Time Factors; D014657:Vasculitis / Q000097:blood / Q000235:genetics / Q000378:metabolism*
chemical_list: D001057:Apolipoproteins E; D024042:Collagen Type I; D024043:Collagen Type II; D004041:Dietary Fats; D008055:Lipids; C502939:ADAMTS13 protein, mouse; D008666:Metalloendopeptidases; D000071120:ADAMTS13 Protein